Covid-19: Export curbs on imported API drugs under review

The commerce and industry ministry is studying a proposal to allow exports of drugs from active pharmaceutical ingredients (API) which have been imported under an advance license wherein duty-free imports are bound to certain export obligations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news